首页> 外文期刊>Infectious Diseases of Poverty >Early detection of neuropathy in leprosy: a comparison of five tests for field settings
【24h】

Early detection of neuropathy in leprosy: a comparison of five tests for field settings

机译:麻风病神经病的早期发现:五个现场设置测试的比较

获取原文
获取外文期刊封面目录资料

摘要

BackgroundEarly detection and treatment of neuropathy in leprosy is important to prevent disabilities. A recent study showed that the Nerve Conduction Studies (NCS) and Warm Detection Thresholds (WDT) tests can detect leprosy neuropathy the earliest. These two tests are not practical under field conditions, however, because they require climate-controlled rooms and highly trained staff and are expensive. We assessed the usefulness of alternative test methods and their sensitivity and specificity to detect neuropathy at an early stage. MethodsThrough a literature search we identified five alternative devices that appeared user-friendly, more affordable, portable and/or battery-operated: the Neuropad?, Vibratip?, NC-Stat?DPNCheck?, NeuroQuick and the Thermal Sensibility Tester (TST), assessing respectively sweat function, vibration sensation, nerve conduction, cold sensation and warm sensation. In leprosy patients in Bangladesh, the posterior tibial and sural nerves that tested normal for the monofilament test and voluntary muscle test were assessed with the NCS and WDT as reference standard tests. The alternative devices were then tested on 94 nerves with abnormal WDT and/or NCS results and on 94 unaffected nerves. Sensitivity and specificity were the main outcomes. ResultsThe NeuroQuick and the TST showed very good sensitivity and specificity. On the sural nerve, the NeuroQuick had both a sensitivity and a specificity of 86%. The TST had a sensitivity of 83% and a specificity of 82%. Both the NC-Stat?DPNCheck? and Vibratip? had a high specificity (88% and 100%), but a low sensitivity (16% and 0%). On the posterior tibial nerve, the NeuroQuick and the TST also showed good sensitivity, but the sensitivity was lower than for the sural nerve. The Neuropad? had a sensitivity of 56% and a specificity of 61%. ConclusionsThe NeuroQuick and TST are good candidates for further field-testing for reliability and reproducibility. The feasibility of production on a larger scale should be examined.
机译:背景早期发现和治疗麻风病对预防残疾很重要。最近的一项研究表明,神经传导研究(NCS)和温检测阈值(WDT)测试可以最早检测出麻风神经病。然而,这两个测试在野外条件下不切实际,因为它们需要气候控制室和训练有素的人员,而且价格昂贵。我们评估了替代测试方法的有用性,以及它们在早期检测神经病变的敏感性和特异性。方法通过文献检索,我们发现了五种替代设备,它们看起来更易于使用,更实惠,便携式和/或由电池供电:Neuropad?,Vibratip?,NC-Stat?DPNCheck?,NeuroQuick和热敏测试仪(TST),分别评估汗液功能,振动感觉,神经传导,冷感觉和热感觉。在孟加拉国的麻风病患者中,以NCS和WDT作为参考标准测试评估了测试正常的单丝测试和自愿性肌肉测试的胫后神经和腓肠神经。然后,对具有WDT和/或NCS结果异常的94条神经以及94条未受影响的神经进行了测试。敏感性和特异性是主要结果。结果NeuroQuick和TST表现出非常好的敏感性和特异性。在腓肠神经上,NeuroQuick的敏感性和特异性均为86%。 TST的敏感性为83%,特异性为82%。两者都是NC-Stat?DPNCheck?和Vibratip?具有高特异性(88%和100%),但敏感性低(16%和0%)。在胫后神经上,NeuroQuick和TST也显示出良好的敏感性,但敏感性低于腓肠神经。神经垫?敏感性为56%,特异性为61%。结论NeuroQuick和TST是进一步进行可靠性和可重复性现场测试的良好选择。应检查大规模生产的可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号